News
Indigo Diabetes Business Update
BELGIUM – Ghent, December 21, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today provides an update on recent and ongoing business activities. Clinical study progress The GLOW study, which...
Indigo Diabetes Appoints Daniël Verstappen as VP Quality Assurance and Regulatory Affairs
We are pleased to announce the appointment of daniel verstappen as VP Quality assurance and regulatory affairs daniel verstappeen - Brings almost three decades of leadership experience in the MedTech space - Helped drive the transformation of Philip Morris...
Indigo Diabetes Receives €3 million Hephaestus Research Grant to Support Development of CMM Technology
BELGIUM - Ghent, September 7, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, is pleased to announce that it has received a €3 million grant from VLAIO, the Flanders organisation for Innovation...
Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board
We are pleased to announce the appointment of Paul Moraviec as Chairman of our Board of Directors Paul Moraviec - Brings decades of leadership experience in the Global MedTech sector - As CEO of ConvaTec Group Plc, led the $5 billion IPO on the London Stock Exchange -...
Our CEO Participates in a Digital Roundtable Event on Innovation
Our CEO and co-founder Danaë Delbeke was one of the 35 CEOs from start-ups and unicorn companies (companies worth more than $1bn), who met on 30th March 2021 in a digital roundtable event organised by the European Commission. The aim of the event which was hosted by...
Initiating our First Clinical Study of our Continuous Glucose Monitoring Sensor
Ground-breaking subcutaneous sensor aims to continuously monitor multiple metabolites including ketones in people living with diabetes BELGIUM - Ghent, March 18, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using...
Indigo at 5th Conference on Digital Health
Join #T5THC on Digital Health. Discover how we can create a sustainable healthcare model. Tom Segers will speak about Indigo's innovative technology as an extra sense for people with diabetes (Track 2 at 14h20). https://www.the5thconference.com/digitalhealth20/
Indigo at EASD – Online session
Watch the online Poster Presentation during the 56th EASD annual meeting! We invite you to watch the presentation of INDIGO Poster #726 @ EASD by Dr. David Stocker: "Accuracy of a subcutaneously inserted NIR spectrometer sensor for continuous glucose, ketone and...
Interview with Danaë Delbeke, CEO
Gent, Belgium – The Belgian business journal De Tijd featured an interview with Danaë Delbeke, CEO of our company Indigo Diabetes. Read Danäe Delbeke's interview with De Tijd. The article is in Dutch. Source:...
Indigo Diabetes concludes a €38 million round of financing
July 27, 2020 - Ghent, Belgium Invisible sensor for people with diabetes aims at measuring multiple metabolites BELGIUM - Ghent, July 27, 2020 – Indigo Diabetes nv, a young high-tech medical device company that develops medical solutions using nanophotonics, today...